Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Stärke
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Packungsgröße
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Form
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Quelle
European Medicines Agency
